Authors


Eric Hoffman

Latest:

OneOncology and Its Practice Partners Celebrate 5 Years of Cancer Care Excellence

“OneOncology was started by physicians and for physicians,” said Jeff Patton, MD, OneOncology CEO. “As we’ve grown and enhanced world-class cancer care in communities across the country, strengthening practice independence and empowering their decision-making has always been our north star."


Leah Lawrence

Latest:

How the Name Change to Myeloproliferative Neoplasms Affected People With the Disease

A decision to rename myeloproliferative neoplasms led to a plethora of developments in a space where there was once little interest.



Stacie B. Dusetzina, PhD

Latest:

Association Between Low-Income Subsidies and Inequities in Orally Administered Antimyeloma Therapy Use

Medicare Part D low-income subsidies alone are insufficient to improve the uptake and equitable use of high-cost, orally administered antimyeloma therapy.


Kevin Wiley Jr, MPH

Latest:

Using Natural Language Processing to Classify Social Work Interventions

Natural language processing can be used for automated extraction of social work interventions from electronic health records, thereby supporting social work staffing and resource allocation decisions.



Joshua R. Vest, PhD

Latest:

Primary Care Case Conferences to Mitigate Social Determinants of Health: A Case Study From One FQHC System

This article describes perceived benefits, facilitators, and challenges of conducting interprofessional team case conferences in primary care settings to address patients’ complex social needs.


Samuel Johnmeyer

Latest:

Contributor: COVID-19’s Impact on ACO REACH Deserves CMS' Attention

CMS must account for inclusion of COVID years in 2023 ACO REACH benchmarks to avoid unfairly penalizing REACH ACOs.


Michael Morse, MD, MHS, FACP

Latest:

mCRC Treatment Access: IRA Cost Cap Impact and Final Insights

Medical experts discuss how the Inflation Reduction Act’s out-of-pocket prescription drug cost cap, effective in 2025, may impact access to oral chemotherapy options for metastatic colorectal cancer.


Julie Munakata, MS

Latest:

US Cost-effectiveness and Budget Impact of Point-of-Care NAAT for Streptococcus

This study evaluates the cost-effectiveness and budget impact to US payers of point-of-care nucleic acid amplification tests (NAAT) for group A streptococcus.


Jeffrey Bendix

Latest:

Physician Groups Mostly Unhappy With Proposed Medicare Fee Schedule

The proposed fee schedule for 2024 would reduce payments by 3.4%. Most responses were swift and negative.


Simrun Grewal, PhD

Latest:

Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model

Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.


Sunil Bhopale, MD

Latest:

Opioid Safety Initiative Associated With Decreased Emergency Department Opioid Prescribing

A scalable health system–wide emergency physician education and feedback initiative was associated with decreased opioid prescribing, in excess of background temporal decline.


Jack Hoadley, PhD

Latest:

Trends in Medicare Part D Coverage of Generics With Equivalent Brand-Name Drugs

High-tier generic drug placement in Medicare Part D has increased over time, but it may be related to a drug’s clinical profile and availability of substitutes rather than preferred brand-name drug coverage.


Bridgette J. Picou, LVN, ACLPN, The Well Project | Image Credit: © Maggie L. Shaw
Bridgette J. Picou, LVN, ACLPN

Latest:

Breaking Silos in HIV and Menopause Care: Bridgette Picou, LVN, ACLPN

An expert on the intersection of HIV and menopause, Bridgette J. Picou, LVN, ACLPN, The Well Project, explains the importance of overcoming siloed care for women living with HIV and going through menopause.


Christopher Wallick, PharmD

Latest:

Outcomes of Antiviral Treatment for Influenza in Type 2 Diabetes

Antiviral treatment was associated with lower health care resource utilization and costs in patients with type 2 diabetes and a diagnosis of influenza.


Richard K. Leuchter, MD

Latest:

Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net

This study evaluates the impact of Choosing Wisely–based interventions on antibiotic prescribing for viral respiratory tract infections in a real-world safety-net setting.



Brian M. Parker, MD

Latest:

Contributor: Why Key Leadership Experiences Are Vital for Developing Future Physician Leaders

As chief quality officer for Allegheny Health Network, Brian M. Parker, MD, is responsible for ensuring that the highest standards of patient care quality, safety, and service excellence are achieved.


Abi Sundaramoorthy, MD, MBA

Latest:

Contributor: Equity, Not Equality, Is Needed to Close Racial Gap in Chronic Kidney Disease Outcomes

Improving clinical care is only one element of the 360-degree, holistic treatment that is necessary to achieve patient equity, not equality, in patients with chronic kidney disease. Biology, lifestyle, and socioeconomic status are 3 areas in which inequities often have a particularly negative impact on a carefully constructed care plan.


Dan N. Huynh, MD

Latest:

Telehealth Transitional Care and 30-Day Readmission During the COVID-19 Pandemic

This study found that the dramatic shift from face-to-face posthospital transitional care to telehealth did not affect 30-day readmission or mortality during the COVID-19 pandemic.


Dawn Schwenke, PhD, MS

Latest:

Implementation of Early Follow-up Care After Heart Failure Hospitalization

An early heart failure follow-up intervention succeeded in increasing referral to and completion of cardiology appointments within 7 days of discharge. The intervention was associated with lower risk of 30-day all-cause emergency department visits, all-cause hospitalizations, or death.


Courtney A. Johnson, MPH

Latest:

Availability of Off-Marketplace Plans With Lower Premiums for Higher-Income Families

Off-marketplace plans are widely available, and individuals with higher incomes can obtain silver plans with low premiums off-marketplace.


Hannah T. Neprash, PhD

Latest:

Artificial Intelligence in Medicare: Utilization, Spending, and Access to AI-Enabled Clinical Software

This study quantified the trends over time in utilization of, spending on, and access to CT fractional flow reserve, the first artificial intelligence (AI)–enabled clinical software reimbursed by Medicare.


Ishmael Tagoe, MPA, CHES

Latest:

Association of Social Risks With Avoiding or Delaying Health Care and With Emergency Department Visits: Evidence From 2017 Ohio Medicaid Assessment Survey

Social risks (food insecurity, housing instability, financial strain, health insurance type) are associated with patients’ decisions to avoid/delay health care and increased utilization of the emergency department.


Greg Cooper, MD, PhD

Latest:

Contributor: The Era of Disease-Modifying Alzheimer Disease Treatments

New treatments for Alzheimer disease don’t reverse cognitive symptoms, but they do significantly slow progression. Evidence suggests that earlier treatment is most effective.


Abhilasha Ramasamy, MSc, MS, BPharm

Latest:

Assessing Opportunities to Advance Quality Measures in Adult Obesity

Obesity is a serious chronic disease and risk factor for a broad range of outcomes. This study identifies opportunities for improving quality in obesity care.


Anastasia G. Daifotis, MD

Latest:

Impact of Delayed Adoption of Novel Atrial Fibrillation Treatments

Using direct oral anticoagulants as a case study, the authors examined how delayed adoption of novel treatments could impact patient health outcomes and cost.


Beth Bortz, MPP

Latest:

A 10-Step Program to Successfully Reduce Low-Value Care

The frequency of low-value care can be reduced by a respectful, data-driven process anchored in nonjudgmental communication and explicit core values.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo